Application Information

This drug has been submitted to the FDA under the reference 022535/001.

Names and composition

"ESBRIET" is the commercial name of a drug composed of PIRFENIDONE.
It belongs to the class Idiopathic pulmonary fibrosis treatments and is used in Cough, congestion, respiratory distress (Respiratory System)

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
022535/001 ESBRIET PIRFENIDONE CAPSULE/ORAL 267MG
208780/001 ESBRIET PIRFENIDONE TABLET/ORAL 267MG
208780/002 ESBRIET PIRFENIDONE TABLET/ORAL 534MG
208780/003 ESBRIET PIRFENIDONE TABLET/ORAL 801MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
022535/001 ESBRIET PIRFENIDONE CAPSULE/ORAL 267MG
208780/001 ESBRIET PIRFENIDONE TABLET/ORAL 267MG
208780/002 ESBRIET PIRFENIDONE TABLET/ORAL 534MG
208780/003 ESBRIET PIRFENIDONE TABLET/ORAL 801MG

Manufacturers

Manufacturer name
Roche Products Ltd

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved